Wixela Inhub Diskus 500/50mcg 60s

Manufacturer MYLAN Active Ingredient Fluticasone and Salmeterol Inhalation Powder(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Some brands are used to treat COPD (chronic obstructive pulmonary disease).It may be given to you for other reasons. Talk with the doctor.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Corticosteroid/Long-acting Beta2-Adrenergic Agonist Combination
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS) and Long-acting Beta2-Adrenergic Agonist (LABA)
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jan 2019
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Wixela Inhub is an inhaler that contains two medicines: fluticasone and salmeterol. Fluticasone is a steroid that helps reduce inflammation in your lungs, making it easier to breathe. Salmeterol is a long-acting bronchodilator that helps open up your airways for 12 hours. This medicine is used twice a day to help prevent asthma symptoms or to manage COPD, but it is not for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To use this medication safely and effectively, follow your doctor's instructions and the information provided below.

Use your inhaler only for breathing in, as directed by your doctor.
Continue using this medication as prescribed by your doctor or healthcare provider, even if you feel well.
Take your medication at the same time every day to establish a routine.
After each use, rinse your mouth with water, then spit out the water without swallowing it.

Using Your Inhaler

If you are using multiple inhaled medications, consult your doctor about which one to use first.
Only prepare a dose when you are ready to take it. If you prepare a dose and close the inhaler without taking it, the medication will be wasted and the inhaler may be damaged.
Avoid breathing out into the inhaler.
After taking your dose, close the inhaler to preserve the medication.
Do not take an extra dose, even if you did not taste or feel the powder.

Caring for Your Inhaler

Do not take the device apart or wash it.
Do not use a spacer with this inhaler.
Avoid breathing out into the device.
Clean the mouthpiece by wiping it with a dry tissue or cloth. Do not wash it or submerge it in water.

Tracking Your Doses

The inhaler has a built-in dose counter to help you keep track of the number of doses remaining.
Dispose of the inhaler when the dose counter reaches "0," or after 1 month from opening the foil pouch, or when the expiration date is reached, whichever occurs first.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding bathrooms.
Keep the inhaler in its foil pouch until you are ready to use it.

Missing a Dose

If you miss a dose, skip it and return to your regular schedule.
* Do not take two doses at the same time or take extra doses to make up for the missed one.
πŸ’‘

Lifestyle & Tips

  • Use the inhaler exactly as prescribed, usually twice a day, about 12 hours apart. Do not use more often than prescribed.
  • This inhaler is not for sudden breathing problems. Always carry a fast-acting rescue inhaler (e.g., albuterol) for acute symptoms.
  • Rinse your mouth with water and spit it out after each dose to help prevent oral thrush (a fungal infection in the mouth). Do not swallow the water.
  • Do not stop using this medicine suddenly without talking to your doctor, even if you feel better.
  • Keep track of your asthma symptoms and peak flow readings (if applicable) and report any worsening to your doctor.
  • Proper inhaler technique is crucial for effectiveness. Your doctor or pharmacist should demonstrate how to use the Diskus device.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: One inhalation of Wixela Inhub 500/50 mcg twice daily, approximately 12 hours apart.
Dose Range: 500 - 500 mg

Condition-Specific Dosing:

asthma: One inhalation of Wixela Inhub 500/50 mcg twice daily.
copd: One inhalation of Wixela Inhub 250/50 mcg twice daily (Note: 500/50 mcg is not indicated for COPD in the US, but 250/50 mcg is common. User specified 500/50, so this is the dose for asthma). For COPD, the 250/50 mcg strength is typically used.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for 500/50 mcg. For children 4-11 years with asthma, lower strengths (e.g., 100/50 mcg) are used.
Adolescent: For adolescents 12 years and older with asthma: One inhalation of Wixela Inhub 500/50 mcg twice daily.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary.
Moderate: No dosage adjustment necessary.
Severe: No dosage adjustment necessary.
Dialysis: No specific recommendations; systemic exposure is low.

Hepatic Impairment:

Mild: No dosage adjustment necessary.
Moderate: Use with caution; monitor for systemic corticosteroid effects.
Severe: Use with caution; monitor for systemic corticosteroid effects. Fluticasone and salmeterol are primarily cleared by hepatic metabolism.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It exerts its effects by binding to glucocorticoid receptors, leading to the activation of anti-inflammatory genes and the repression of pro-inflammatory genes. This reduces inflammation in the airways, decreasing bronchial hyperreactivity and mucus production. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It selectively stimulates beta2-adrenergic receptors on bronchial smooth muscle cells, leading to activation of adenyl cyclase, increased intracellular cyclic AMP (cAMP) levels, and subsequent relaxation of bronchial smooth muscle, resulting in bronchodilation.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: Low systemic bioavailability (<1-2% for orally inhaled dose). Salmeterol: Low systemic bioavailability (<5% for orally inhaled dose).
Tmax: Fluticasone: 0.5-1 hour. Salmeterol: 5-10 minutes.
FoodEffect: Not applicable for inhaled powder.

Distribution:

Vd: Fluticasone: Approximately 318 L. Salmeterol: Approximately 1580 L.
ProteinBinding: Fluticasone: Approximately 91%. Salmeterol: Approximately 96%.
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: Approximately 8 hours (terminal). Salmeterol: Approximately 5.5 hours (terminal).
Clearance: Fluticasone: High systemic clearance (approximately 1150 mL/min). Salmeterol: High systemic clearance (approximately 1200 mL/min).
ExcretionRoute: Fluticasone: Primarily fecal (as metabolites). Salmeterol: Primarily fecal (approximately 60%) and renal (approximately 25%) as metabolites.
Unchanged: Fluticasone: <5% in urine. Salmeterol: <1% in urine.
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (significant bronchodilation). Fluticasone: Anti-inflammatory effects develop over days to weeks.
PeakEffect: Salmeterol: 2-4 hours. Fluticasone: Weeks for maximal therapeutic benefit.
DurationOfAction: Salmeterol: 12 hours. Fluticasone: Sustained anti-inflammatory effect with twice-daily dosing.
Confidence: High

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and effectiveness of Wixela Inhub in patients with asthma have not been established in patients who are adequately controlled on an inhaled corticosteroid alone. Wixela Inhub is not indicated for the relief of acute bronchospasm.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal.
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat.
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss.
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision.
Chest pain or pressure.
Rapid or abnormal heartbeat.
Shakiness.
Feeling nervous or excitable.
Changes in behavior.
Vision changes, eye pain, or severe eye irritation.
Unusual burning, numbness, or tingling sensations.
Choking.
Changes in voice.
Seizures.
Bone pain.
Sleep disturbances.
Feeling extremely tired or weak.
Vaginal itching or discharge.
Weight gain.
Mouth irritation or mouth sores.
Redness or white patches in the mouth or throat.

Important Warning: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Possible Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or persist:

Headache.
Nausea or vomiting.
Throat irritation.
* Common cold symptoms.

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma or COPD symptoms (e.g., increased shortness of breath, wheezing, cough, chest tightness)
  • Increased need for your rescue inhaler
  • Sudden worsening of breathing immediately after using the inhaler (paradoxical bronchospasm)
  • Signs of infection (e.g., fever, chills, body aches, increased mucus, change in mucus color)
  • White patches in your mouth or throat (oral thrush)
  • Signs of allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, severe dizziness, trouble breathing)
  • Heart palpitations, chest pain, fast heart rate, or tremor
  • Vision changes (e.g., blurred vision, eye pain, halos around lights)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking, as some may interact with this medication. Specifically, certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
If you have a milk allergy.
This is not an exhaustive list of all potential interactions. Therefore, it is crucial to discuss all your medications, health problems, and supplements with your doctor and pharmacist to ensure safe use.

To guarantee your safety, inform your doctor and pharmacist about all the following:
All prescription and OTC medications you are taking
Any natural products or vitamins you are using
Your health problems

Before making any changes to your medication regimen, including starting, stopping, or adjusting the dose of any medication, consult your doctor to ensure it is safe to do so with this medication.
⚠️

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

Effectiveness and Monitoring
It may take approximately 1 week to experience the full effects of this medication. If you have diabetes (high blood sugar), consult your doctor, as this drug may increase blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Dosage and Administration
Do not exceed the prescribed dose or use this medication more often than directed. Overdose can be fatal, so it is crucial to follow your doctor's instructions. If you have any concerns, discuss them with your doctor.

Transitioning from Oral Steroids
When switching from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

Stressful Situations
In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in these situations.

Long-term Use and Potential Risks
Prolonged use of this medication may increase the risk of developing cataracts or glaucoma. Consult your doctor about this potential risk. Additionally, long-term use may cause osteoporosis (weak bones). Discuss your risk factors with your doctor and undergo bone density tests as recommended.

Infection Prevention
To minimize the risk of infection, practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Viral Infections
If you have not had chickenpox or measles before, avoid exposure to these viruses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed, consult your doctor.

Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. In children and adolescents, this medication may affect growth in some cases, so regular growth checks may be necessary. Consult your doctor about this potential risk.

Pregnancy and Breastfeeding
If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor.

COPD Considerations
If you have chronic obstructive pulmonary disease (COPD), you are at a higher risk of developing pneumonia. This medication may further increase this risk, so discuss this with your doctor.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Salmeterol overdose: Tachycardia (fast heart rate), arrhythmias, tremor, nervousness, headache, nausea, muscle cramps, hypokalemia, hyperglycemia.
  • Fluticasone overdose (acute): Adrenal suppression (usually transient), no specific treatment needed beyond monitoring.
  • Fluticasone overdose (chronic): Cushingoid features (e.g., moon face, buffalo hump), adrenal suppression, growth retardation in children, bone demineralization, cataracts, glaucoma.

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic. Monitor cardiac function (ECG), serum potassium, and blood glucose. Consider a cardioselective beta-blocker for severe cardiac symptoms, but use with extreme caution due to risk of bronchospasm.

Drug Interactions

🚫

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, cobicistat-containing products) due to increased systemic exposure to fluticasone and salmeterol, leading to increased risk of cardiovascular and systemic corticosteroid adverse effects.
  • Other long-acting beta2-adrenergic agonists (LABAs) due to increased risk of cardiovascular adverse effects.
πŸ”΄

Major Interactions

  • Beta-blockers (non-cardioselective): May block the bronchodilatory effect of salmeterol and cause severe bronchospasm, especially in patients with asthma. Use with caution and only if no suitable alternative.
  • Diuretics (loop or thiazide): May potentiate ECG changes and/or hypokalemia associated with beta-agonists, especially at high doses.
  • Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs): May potentiate the cardiovascular effects of salmeterol (e.g., arrhythmias, hypertension). Use with extreme caution or avoid within 2 weeks of discontinuing MAOIs.
  • Drugs that prolong the QT interval (e.g., Class IA and III antiarrhythmics, certain antihistamines, macrolides): Increased risk of ventricular arrhythmias with salmeterol.
🟑

Moderate Interactions

  • Other sympathomimetics: Additive cardiovascular effects.
  • Xanthine derivatives (e.g., theophylline): May potentiate hypokalemia and ECG changes.
🟒

Minor Interactions

  • Not specifically identified as minor, but general caution with drugs affecting electrolyte balance.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary Function Tests (PFTs)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy.

Adrenal Function (e.g., morning cortisol)

Rationale: Consider if patient has been on high-dose systemic corticosteroids or is at risk for adrenal suppression.

Timing: Prior to initiation, especially if transitioning from oral corticosteroids.

Electrolytes (Potassium)

Rationale: Salmeterol can cause transient hypokalemia.

Timing: Prior to initiation, especially in patients at risk or on concomitant diuretics.

Ocular Examination (intraocular pressure, cataracts)

Rationale: Long-term use of ICS can increase risk of glaucoma and cataracts.

Timing: Prior to initiation, especially in patients with pre-existing ocular conditions or risk factors.

πŸ“Š

Routine Monitoring

Pulmonary Function Tests (PFTs)

Frequency: Periodically (e.g., every 6-12 months or as clinically indicated)

Target: Improvement or stabilization of FEV1, FVC, etc.

Action Threshold: Worsening lung function or lack of improvement may indicate inadequate control or need for re-evaluation.

Asthma/COPD Symptom Control

Frequency: Regularly (e.g., at each visit, patient self-monitoring)

Target: Reduced frequency of symptoms, reduced rescue inhaler use, improved quality of life.

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings, or exacerbations.

Growth (in pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age.

Action Threshold: Growth deceleration; consider lowest effective dose.

Bone Mineral Density (BMD)

Frequency: Periodically, especially for patients at high risk for osteoporosis or on long-term high-dose ICS.

Target: Stable BMD.

Action Threshold: Significant bone loss; consider bone protective measures.

Oral Cavity Inspection

Frequency: At each visit

Target: Absence of oral candidiasis.

Action Threshold: Presence of white patches; treat with antifungal and reinforce rinsing mouth after use.

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma/COPD symptoms (e.g., increased shortness of breath, wheezing, cough)
  • Increased need for rescue inhaler (short-acting beta-agonist)
  • Paradoxical bronchospasm (immediate worsening of breathing after inhalation)
  • Signs of oral candidiasis (white patches in mouth or throat)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, mood changes)
  • Signs of infection (e.g., fever, chills, increased sputum production, change in sputum color)
  • Cardiovascular symptoms (e.g., palpitations, chest pain, tremor, nervousness)

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies of fluticasone/salmeterol in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Poorly controlled asthma in pregnancy poses risks to both mother and fetus.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though systemic exposure is low. Risk vs. benefit should be carefully weighed.
Second Trimester: Generally considered safer than first trimester, but still Category C. Monitor for fetal growth.
Third Trimester: Risk of transient neonatal hypoglycemia and hypokalemia with beta-agonists if used close to delivery. Monitor neonate.
🀱

Lactation

Caution is advised. It is unknown if fluticasone or salmeterol are excreted in human milk. Systemic levels are low after inhalation. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Wixela Inhub and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition.

Infant Risk: L3 (Moderate risk). Potential for infant exposure, though likely low. Monitor for signs of systemic corticosteroid effects (e.g., growth suppression) or beta-agonist effects (e.g., irritability, tremor, tachycardia).
πŸ‘Ά

Pediatric Use

Wixela Inhub 500/50 mcg is indicated for asthma in adolescents 12 years and older. Lower strengths are available for younger children. Monitor growth velocity in pediatric patients receiving ICS, as they may experience a reduction in growth velocity. The lowest effective dose should be used.

πŸ‘΄

Geriatric Use

No dosage adjustment is generally required. However, elderly patients may be more susceptible to the cardiovascular effects of salmeterol (e.g., tremor, palpitations) and systemic corticosteroid effects (e.g., bone density loss, cataracts, glaucoma). Monitor for comorbidities and concomitant medications.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Wixela Inhub is a maintenance medication and should be used regularly, even when symptoms are absent. It is NOT a rescue inhaler.
  • Emphasize proper Diskus inhaler technique, including loading the dose, exhaling fully away from the device, inhaling rapidly and deeply, holding breath, and rinsing mouth.
  • Patients should be instructed to always have a short-acting beta-agonist (SABA) available for acute asthma symptoms.
  • Counsel patients on the black box warning regarding the increased risk of asthma-related death with LABAs, and that this combination should only be used when ICS alone is insufficient.
  • Monitor for signs of oral candidiasis and reinforce mouth rinsing after each dose.
  • Be aware of potential drug interactions, especially with strong CYP3A4 inhibitors and beta-blockers.
  • For patients transitioning from oral corticosteroids, monitor for adrenal insufficiency and taper oral steroids slowly.
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroids (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone) for patients whose asthma is controlled on ICS alone.
  • Long-acting Muscarinic Antagonists (LAMAs) (e.g., tiotropium) for COPD.
  • Oral corticosteroids (for severe exacerbations or refractory disease).
  • Leukotriene receptor antagonists (e.g., montelukast).
  • Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma.
  • Short-acting beta-agonists (SABAs) for rescue relief.
πŸ’°

Cost & Coverage

Average Cost: $250 - $400 per 60 doses (one inhaler)
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (for generic Wixela Inhub, often preferred over brand Advair Diskus)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the amount, and the time it occurred.